KLRS

Kalaris Therapeutics

85 hedge funds and large institutions have $294M invested in Kalaris Therapeutics in 2022 Q3 according to their latest regulatory filings, with 17 funds opening new positions, 34 increasing their positions, 22 reducing their positions, and 16 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
85
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$267K
Puts
$180K
Net Calls
Net Calls Change

Top Buyers

1 +$25.7M
2 +$17.1M
3 +$8.56M
4
GC
GMT Capital
Georgia
+$6.85M
5
Vanguard Group
Vanguard Group
Pennsylvania
+$6.81M
Name Holding Trade Value Shares
Change
Change in
Stake
51
$114K
52
$114K
53
$111K
54
$104K
55
$102K
56
$101K
57
$100K
58
$98K
59
$90K
60
$89K
61
$58K
62
$51K
63
$37K
64
$31K
65
$25K
66
$23K
67
$20K
68
$18K
69
$16K
70
$15K
71
$14K
72
$10K
73
$7K
74
$6K
75
$6K